Basket Updated
0
Items added
Products and Related Resources for Adaptive Immune Response SARS-CoV-2 Research
This interactive guide shows the key cell and functional state markers for tumor-infiltrating immune cells in humans.Web Location: Immunology and Inflammation
Cell Signaling Technology Chief Scientific Officer, Dr. Roby Polakiewicz, to Speak on Two Panels at the Global Biological Standards Institute (GBSI) Antibody Validation Workshop
Through the nonprofit Seeding Labs, CST donates lab equipment to research organizations around the world, including a university in Malawi.
For years, the TME could only be viewed in single-cell snapshots by flow cytometry or limited tissue staining. IMC offers a panorama of this dynamic world.
The immune system is composed of tissues, cells, and molecules whose primary function is to detect, respond to, and eliminate pathogens and transformed cells.
In this webinar, the speakers will explore how tumors exploit immune modulatory mechanisms to generate and thrive in their own immunosuppressive microenvironment, and explain how PD-1 immunotherapy stops certain cancers from turning off the anticancer immune response.
Cell Signaling Technology CEO and Founder Dr. Michael Comb wins lifetime achievement award.
Products and Related Resources for Virus Detection and Innate Immune Activation SARS-CoV-2 Research
Dr. Michael J. Comb Receives CiteAb Lifetime Achievement Award
Cigall Kadoch PhD keeps a running list of targets to advance mechanistic studies of human disease. Here, Dr. Kadoch discusses the value of collaborating with CST to develop novel reagents to probe ATP-dependent chromatin remodeling complexes.
CST is proud to partner with global green chemistry nonprofit Beyond Benign to support the creation of green chemistry teaching resources for STEM education.
In this webinar, Dr. Reuben Shaw will explore new findings in the field of AMPK and Autophagy signaling.
Watch this webinar for applications, tips, and tricks for Simple Western, for fast, reliable, and hands-free automated western blotting using CST antibodies. See an overview of the CST-Bio-Techne partership, brining westerns into the 21st century.
Abnormal cell-cell communication, for example disrupted presynaptic input, as well as disrupted intracellular signaling contribute to the pathogenesis of neurodegenerative disease.
Streamline your oncology therapeutic development with CST recombinant monoclonal antibodies, ELISA and cellular assay kits, custom products, and services.
In this webinar the speakers will explore how the tumor microenvironment promotes oncogenic progression, while protecting the tumor from therapeutic intervention.
At AACR 2023, many presentations focused on topics including cancer immunology, CAR-T therapy, spatial biology, mRNA vaccines, and KRAS.
Dr. David Rimm of Yale School of Medicine discusses multiplexing spatial imaging technologies and their development to improve response prediction for immunotherapy. This webinar was recorded at AACR 2022.
Use our protocol compatibility table to understand which immune signaling and phenotyping antibodies will work together in your multicolor flow cytometry experiment.
To help cancer researchers to push their field forward, CST scientists dig into the literature to identify unmet needs. Dr. Cigall Kadoch shares her thoughts on what makes CST antibody development and validation unique in this video.
As the importance of the mammalian SWI/SNF (BAF) complexes in contributing to cancer became apparent, Dr. Kadoch realized there was a real lack of reagents to effectively study this class of proteins.
Cell Signaling Technology (CST), a worldwide provider of antibodies, participated in the 2016 Global Biological Standards Institute (GBSI) Antibody Validation: Standards, Policies and Practices Workshop
CST donates lab equipment to Seeding Labs, a non-profit helping scientists in developing countries. Read the interview with Dr. Lillianfeld to learn more.
Neuroinflammation is a condition observed in the central nervous system (CNS) in response to infection, toxic metabolites, traumatic injury, or autoimmunity.
Video: the updated CUT&RUN kit provides improved results, confirmed compatibility with fixed frozen cells, tissues, and primary cells, uses even fewer cells.
Cell Signaling Technology is the lucky recipient of Antibody Company of the Year and Antibody Company Succeeding in Cancer Biology awards from CiteAb.
New antibodies for Alzheimer's research were presented at SfN 2022, including tools to study neuroinflammation in glial cells like microglia and astrocytes